HIGHLIGHTS
- who: Eline van Diest et al. from the Johannes Gutenberg Mainz, Germany have published the research: The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers, in the Journal: (JOURNAL)
- what: GABs are made by the fusion of the ectodomains of a gdTCR to an anti-CD3 single chain variable fragment (scFv) (gdECTO-aCD3), here the authors explore alternative designs with the aim to enhance GAB effectivity. The authors show that dimers are a natural by-product of the recently reported gdECTO-aCD3 design, and that gdECTO-aCD3-dimers have higher activity . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.